Incidence of Non Adherence to Treatment With Once-daily Formulation of Tacrolimus
Status:
Unknown status
Trial end date:
2018-08-01
Target enrollment:
Participant gender:
Summary
Aim The primary objective of this study is to compare medication adherence with medical
therapy in patients receiving once-daily versus twice-daily tacrolimus regimens.
Participants 60 adult renal transplant patients randomized 1:2 into twice-daily and
once-daily tacrolimus groups
Outcomes The primary outcome will be medication adherence to the once-daily and twice-daily
regimens, measured in terms of implementation. Secondary outcomes will include graft and
patient survival, renal function and adverse events. Follow up - 12 months